Skip to content
Evaluation CAPES Module #2: Understanding and Managing Pain and Fatigue in SpA and PsA
Demographic Questions
1.
Please provide your name and email address.
Name
Email Address
2.
What is your specialty?
Dermatology
Rheumatology
Primary Care
Other (please specify)
3.
Please indicate your practice setting.
Academic
Community
4.
Number of patients seen/impacted per week.
Activity Objectives: Please rate your level of achievement.
5.
Understand the neurobiology of pain processing.
Outstanding
Good
Average
Fair
Poor
6.
Explain the assessment of pain in clinical trials and clinical practices.
Outstanding
Good
Average
Fair
Poor
7.
Examine the impact of central sensitization and fibromyalgia on pain assessments and outcomes in PsA and axSpA.
Outstanding
Good
Average
Fair
Poor
8.
Examine why fatigue is a “core” outcome in rheumatic diseases including psoriatic arthritis.
Outstanding
Good
Average
Fair
Poor
9.
Review what may cause fatigue.
Outstanding
Good
Average
Fair
Poor
10.
Identify ways to assess fatigue.
Outstanding
Good
Average
Fair
Poor
11.
Examine how to treat fatigue.
Outstanding
Good
Average
Fair
Poor
Evaluation of the Presenters
12.
The
content
of the presentation given by Melissa Leeolou was:
Outstanding
Good
Average
Fair
Poor
13.
The
delivery
of the presentation given by Melissa Leeolou was:
Outstanding
Good
Average
Fair
Poor
14.
Did Melissa Leeolou appear
objective
and
unbiased
by commercial interests?
Yes
No
If no, please explain:
15.
The
content
of the presentation given by Minionette “Mini” Wilson was:
Outstanding
Good
Average
Fair
Poor
16.
The
delivery
of the presentation given by Minionette “Mini” Wilson was:
Outstanding
Good
Average
Fair
Poor
17.
Did Minionette “Mini” Wilson appear
objective
and
unbiased
by commercial interests?
Yes
No
If no, please explain:
18.
The
content
of the presentation given by Philip Mease, MD, was:
Outstanding
Good
Average
Fair
Poor
19.
The
delivery
of the presentation given by Philip Mease, MD, was:
Outstanding
Good
Average
Fair
Poor
20.
Did Philip Mease, MD, appear
objective
and
unbiased
by commercial interests?
Yes
No
If no, please explain:
21.
The
content
of the presentation given by Ernest Choy, MD, FRCP (UK), was:
Outstanding
Good
Average
Fair
Poor
22.
The
delivery
of the presentation given by Ernest Choy, MD, FRCP (UK), was:
Outstanding
Good
Average
Fair
Poor
23.
Did Ernest Choy, MD, FRCP (UK), appear
objective
and
unbiased
by commercial interests?
Yes
No
If no, please explain:
24.
As a moderator, Philip Mease, MD, was:
Outstanding
Good
Average
Fair
Poor
Relevance and Application
25.
Was the information in this activity relevant to your practice or professional development?
Yes
No
26.
I learned new information about SpA and PsA as a result of this program.
Yes
No
27.
Based on the information you received today, do you plan on changing your practice?
Yes, I intend to change the therapy that I render
Yes, I intend to alter the way that I evaluate my patients
Yes, I intend to change the legal/documentation/financial management of my practice
Yes, it may affect my patient referrals
No, but it did confirm my current practice
No, because it doesn’t directly apply to my practice
No, but it did increase my knowledge of community resources
No, because the information was inadequate and/or inaccurate
Other (please elaborate)
28.
How would you rate the presentation overall?
Outstanding
Good
Average
Fair
Poor
29.
Please let us know about any other comments you have:
